MyFinsight
Home
Blog
About
Proceeds from marketable
securities
$79,606K
(-36.98%↓ Y/Y)
Net cash provided by
investing activities
$17,074K
(-18.41%↓ Y/Y)
Effect of exchange rate
changes on cash and cash...
$24K
(130.77%↑ Y/Y)
Canceled cashflow
$62,532K
Net change in cash
and cash...
-$64,869K
(-301.77%↓ Y/Y)
Canceled cashflow
$17,098K
Issuance of common stock
on exercise of...
$2,888K
(33.95%↑ Y/Y)
Stock-based compensation
expense
$11,334K
(-7.65%↓ Y/Y)
Non-cash interest
expense related to sale...
$6,508K
Depreciation of property and
equipment
$957K
(-48.71%↓ Y/Y)
Amortization of operating
lease right-of-use...
$821K
(-42.59%↓ Y/Y)
Deferred income tax
recovery
-$265K
(-189.83%↓ Y/Y)
Amortization of intangible
assets
$176K
(-94.54%↓ Y/Y)
Amortization of debt issuance
costs
$87K
Purchases of marketable
securities
$62,532K
(-39.98%↓ Y/Y)
Net cash provided by
financing activities
-$50,019K
(-1998.25%↓ Y/Y)
Net cash (used in)
provided by operating...
-$31,948K
(-468.66%↓ Y/Y)
Canceled cashflow
$2,888K
Canceled cashflow
$20,148K
Purchases of common stock
for retirement
$51,949K
Net loss
-$45,019K
(-121.56%↓ Y/Y)
Payments for transaction
costs related to sale...
$958K
Accounts payable and
accrued liabilities
-$3,617K
(87.23%↑ Y/Y)
Accounts receivable
$1,256K
(102.36%↑ Y/Y)
Operating lease
liabilities
-$783K
(52.02%↑ Y/Y)
Non-cash royalty revenue
related to sale of...
$467K
Prepaid expenses and
other current assets
$383K
(104.58%↑ Y/Y)
Unrealized foreign
exchange (gain) loss
$301K
(144.40%↑ Y/Y)
Deferred revenue
-$248K
(98.86%↑ Y/Y)
Income taxes payable
-$22K
(18.52%↑ Y/Y)
Back
Back
Cash Flow
Zymeworks Inc. (ZYME)
Zymeworks Inc. (ZYME)
source: myfinsight.com